foxo4-dri synthesis (Proxofim) 10mg*10 vials - Nexus peptides The disordered p53 transactivation domain
The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications FOXO4 DRI regulates endothelial cell senescence via the P53 signaling pathway PMC FOXO4 DRI Peptide 10 mg FOXO4 DRI alleviates age related testosterone secretion insufficiency by targeting senescent Leydig cells in aged mice PMC FOXO4 DRI Peptide Dosing Guide: Senolytic Peptide Protocol (June 2026) FOXO4 DRI Dosing: 1mg Senolytic Protocol (2026)
Pay in 4 interest-free payments of $5.97 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11





